MD Anderson Cancer Center
University of Texas MD Anderson Cancer Ctr
1515 Holcombe Boulevard
Box 423
Houston,
TX
77030-4009
Direct phone: (713) 792-8750
http://www.mdanderson.org/
MD Anderson Cancer Center
Location
Total transplants by cell source
From January 1, 2021 to December 31st, 2022
- Marrow: 174
- PBSC: 551
- Cord Blood: 19
- Autologous (PBSC or Marrow): 643
Performs adult; pediatric transplants
About the center
Overview
MD Anderson is a joint adult and pediatric transplant program that performs both ablative and non-myeloablative transplants, using cord blood, bone marrow or peripheral blood as the source of stem cells. Our expertise includes cord blood, haplo-identical and mismatched related or unrelated transplants. The program is a leader in its cellular therapy treatments including Immune Effector Cells and expanding research protocols.
This center has been performing allogeneic transplants since 1990 and has been an NMDP/Be The Match transplant center since June 1990.
Attending physicians
Adult - Sairah Ahmed, Gheath Al-Atrash, Amin Alousi, Qaiser Bashir, Richard Champlin, George Chen, May Daher, Chitra Hosing, Jin Seon Im, Partow Kebriaei, Issa Khouri, Paul Lin, David Marin, Yago Nieto, Amanda Olson, Betul Oran, Uday Popat, Muzaffar Qazilbash, Hind Rafei, Jeremy Leon Ramdial, Katy Rezvani, Neeraj Saini, Elizabeth J. Shpall
Pediatric - Sajad Khazal, Demetrios Petropoulos, Priti Tewari
Transplants performed
Marrow/PBSC, single cord, and double cord
Cord blood transplants performed on
Adult and pediatric
Other programs and services
Patient Housing during the actual transplant process may be available for patients who meet certain criteria including the receipt of MD Anderson's supplemental financial assistance. The Social Work Counselor shall determine eligibility based on assessment. Patients are expected to follow certain guidelines when using these programs/resources and must contact the Social Work Counselor for assistance. Other housing options, such as local apartment programs and hotels are available for non-indigent and out of state patients, however these are not paid for by MD Anderson Cancer Center. These options vary in cost and are discussed in detail during the social work assessment prior to transplant. Pediatric patients and families may also have access to the Ronald McDonald house. The Pediatric and Adult services both have education manuals, which cover the information that the patient needs to know and is the basis for teaching. This is given to the patient at the start of SCTCT process (pre-admission) and is used by the different disciplines in their one-on-one teaching with the patient and caregiver. Inpatient care needs are assessed and carried out by multidisciplinary care teams. Patient care rounds occur daily on the inpatient SCTCT units. Participating in the rounds are physicians, Fellows, Pharm Ds, Clinical Nurse Leaders (CNLs) & RNs. Multidisciplinary team rounds occur weekly and are attended by representatives from all SCTCT patient care services including CNLs, nurses, case managers, nutritionists, chaplains, psychologists, physical therapists, and social workers. Long term patients and patients with complex care needs are also managed by Individualized Care Plans developed by CNLs and unit nurses who set goals and develop and manage individualized, patient-centered care plans. Physical activity is encouraged and supported through an incentive-based walking program, therapist led exercise classes, and use of a patient exercise gym located on the unit.
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2019, 2020, 2021, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 914 patients.
The actual 1-year survival of these patients is 71.6%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 69.8% and 75.3%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Number of adult transplants
Total adult transplants
1348
Transplants reported (From January 1, 2021 to December 31st, 2022 as reported by the centers)
| Marrow | PBSC | Cord blood | Total | |
|---|---|---|---|---|
| Allogeneic | ||||
| Related donor | 113 | 221 | 0 | 334 |
| Unrelated donor | ||||
| Total allogeneic | 161 | 545 | 9 | 715 |
| Autologous | ||||
| Both marrow & PBSC 633 |
-- | 633 | ||
| Total combined | ||||
| 1339 | 9 | 1348 | ||
Number of pediatric transplants
Total pediatric transplants
39
Transplants reported (From January 1, 2021 to December 31st, 2022 as reported by the centers)
| Marrow | PBSC | Cord blood | Total | |
|---|---|---|---|---|
| Allogeneic | ||||
| Related donor | 11 | 4 | 0 | 15 |
| Unrelated donor | 2 | 2 | 10 | 14 |
| Total allogeneic | 13 | 6 | 10 | 29 |
| Autologous | ||||
| Both marrow & PBSC 10 |
-- | 10 | ||
| Total combined | ||||
| 29 | 10 | 39 | ||
Transplants by disease
All diseases
Number of transplants by age reported from January 1, 2021 to December 31st, 2022 (includes marrow, PBSC and cord blood)
| 0-18 | 19-44 | 45-64 | 65+ | Total | |
|---|---|---|---|---|---|
| Related | 17 | 97 | 143 | 92 | 349 |
| Unrelated | 16 | 86 | 152 | 141 | 395 |
| Autologous | 11 | 145 | 295 | 192 | 643 |
| Total | 44 | 328 | 590 | 425 | 1387 |
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
- U.S. Transplant Data by Center report at bloodcell.transplant.hrsa.gov
- List of diseases
Additional information
Transplant center resources
Transplant center coordinator:
Michele Alvarez
(713) 745-3216
Email: mwallis@mdanderson.org
Financial representative:
Elvira Cruz
(713) 745-6968
Email:
ecruz@mdanderson.org
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
Survivorship program
Loading survivorship program information...